Palantir just posted one of the strongest quarters in its history as a public company. Wall Street‘s reaction was split. The stock fell. And one analyst said he had never seen anything quite like it at this scale.

That analyst was Rosenblatt Securities’ John McPeake. And he responded by raising his price target.

Rosenblatt raises Palantir stock price target

McPeake raised his price target on Palantir to $225 from $200 on May 5, maintaining a buy rating, according to TipRanks. The move followed Palantir’s Q1 2026 earnings report, which McPeake described as a “significant beat” to estimates.

McPeake also raised his estimates following the results. The revised target of $225 places Rosenblatt among the more bullish voices…